乳腺癌相关抗原抗体
Breast carcinoma associated antigen DF3; Breast carcinoma associated antigen DF3; Breast carcinoma-associated antigen DF3; CA 15 3; CA 15-3; CA15 3; CA15 3 antigen; CA15.3; Cancer antigen 15-3
促胃泌素受体抗体
Gastrin receptor; GASR; CCK B; CCK B receptor; CCK BR; CCK-B receptor; CCK-BR; CCK2 R; CCK2 receptor; CCK2-R; CCKB; CCKB receptor; CCKBR; CCKR Type B; CCKRB; Cholecystokinin 2 receptor; Cholecystokini
轴突蛋白1β/Neurexin 1β抗体
Neurexin I beta; Neurexin 1; Neurexin 1 beta; Neurexin I beta; NRXN1; NRX1B_HUMAN.
Anti-PARP Monoclonal Antibody
Anti-PARP Monoclonal Antibody 应用 WB IHC 稀释比例 WB 1:1000-3000. IHC 1:200-500. 交叉反应 Human
磷酸化桩蛋白Paxillin抗体
PXN(phospho S178); Paxillin (phospho S178); Paxillin (phospho Ser178); p-Paxillin (Ser178); Paired box protein Pax 1; PAX 1; PAX1; Paxillin alpha; PXN; PXN protein; FLJ16691; FLJ23042; FLJ16691; PAXI_
核孔复合蛋白Nup214抗体
214 kDa nucleoporin; CAIN; CAN; CAN protein putative oncogene; D9S46E; N214; NU214_HUMAN; Nuclear pore complex protein Nup214; nucleoporin 214kDa; Nucleoporin Nup214; Nup214; p250; Protein
磷酸化血小板源性生长因子受体-α抗体
PDGF Receptor alpha (phospho Y754); p-PDGF Receptor alpha (phospho Y754); PDGF Receptor alpha; Plateletdirived growth factor receptor-alpha; Alpha platelet derived growth factor receptor; CD 140a; CD1